Home Regulatory

Regulatory

EMA-FDA joint principles for the use of AI along medicines lifecycle

staff -
EMA, AI and digitalization

QIG workplan 2026-2028: AI, digitalisation and advanced manufacturing

staff -

Proposed simplification of the MDR and IVDR regulations

Giuliana Miglierini -

The new implementing regulation on the rules for joint clinical assessments

Manuele Cantù -

Updates to the Q&A’s on the EU-US mutual recognition agreement

Manuele Cantù -

The use of titanium dioxide in medicinal products

Manuele Cantù -

The European Council adopted its position on the Pharmaceutical package

Manuele Cantù -

Data and AI in medicines regulation, the workplan to 2028

Giuliana Miglierini -

AUDA-NEPAD is the new PIC/S associated partner

staff -

Towards the implementation of the electronic product information

Manuele Cantù -
123...5Page 1 of 5
© © 2026 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151